Accelerated Transcranial Magnetic Stimulation for Major Depressive Disorder
Neuronetics
Summary
An open-label, multi-center, prospective study to evaluate feasibility and efficacy of accelerated TMS for patients with Major Depressive Disorder (MDD).
Description
This protocol will investigate the feasibility, tolerability and clinical efficacy of an accelerated TMS protocol delivering 36 sessions in 5 days
Eligibility
- Age range
- 15+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Male or female 2. 15 years and older 3. Able to provide informed consent or/and assent 4. Diagnosed with major depressive disorder (MDD) and currently experiencing a major depressive episode (MDE) 5. Adult participants failed to respond to at least one prior anti-depressant medication; for adolescent participants, TMS therapy is used as an adjunct treatment as stated in the FDA cleared indications, but failure to respond adequately to prior anti-depressant medication is not required 6. Participant prescribed TMS Therapy to treat MDD by his or her physician independent o…
Interventions
- DeviceTMS
transcranial magnetic stimulation - DASH 36 treatment delivered in 5 days
Locations (3)
- Brighter NeurotherapeuticsNew York, New York
- TMS of the CarolinasCharlotte, North Carolina
- New chapter TMSSpokane, Washington